Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 154   

Articles published

VRX 26.94 -0.18 (-0.66%)
price chart
Analysts Cautious on Valeant Pharmaceuticals Intl Inc (VRX) and Gilead ...
It's not all bullish in the biotech sector. Analysts remains bearish and neutral on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Gilead Sciences, Inc. (NASDAQ:GILD), respectively, as Valeant faces legal battles and Gilead gains new FDA dosing ...
Here's Why Valeant Pharmaceuticals Intl Inc (VRX) Price Target Has Been Cut  TCC
Valeant Pharmaceuticals Intl Inc.: Is It Going to Default?  The Motley Fool Canada
Canadian Stocks To Watch in U.S. Markets: Valeant Pharmaceuticals ...
Valeant Pharmaceuticals International, Inc. (VRX) ended last trading session with a change of 3.87 percent. It trades at an average volume of 33.95M shares versus 22.34M shares recorded at the end of last trading session.
Valeant Pharmaceuticals International Inc said to weigh sale of skin, cancer ...
Valeant Pharmaceuticals International Inc. is exploring the sale of some of its smaller cosmetic and pharmaceutical assets, according to people familiar with the matter, as the Canadian drugmaker scrambles to raise cash and reduce debt.
What Analysts Suggest About Valeant Pharmaceuticals Intl Inc (NYSE:VRX ...  The Point Review
Zacks' Insights: Valeant Pharmaceuticals Intl Inc (VRX), Apple Inc. (AAPL)  Smarter Analyst
Valeant Pharmaceuticals International Inc.'s business model 'enormously flawed ...
Warren Buffett, the billionaire chairman of Berkshire Hathaway Inc., faulted Valeant Pharmaceuticals International Inc.'s habit of pursuing strategies that looked good in the short term but were doomed to come to a bad end.
Warren Buffett And Charlie Munger Agree: Valeant Was A 'Sewer' And ...  Benzinga
Valeant Pharmaceuticals Faces 3 Tough Hurdles  Seeking Alpha
Notable Runners of Healthcare Sector: Valeant Pharmaceuticals Intl Inc (NYSE ...
Shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) gained 3.87% to $27.12 on Thursday. The company offered net profit margin of -2.80% while its gross profit margin was 75.30%.
Valeant Pharma Appoints Tyco Executive Sam Eldessouky as Corporate ...  Sonoran Weekly Review
Valeant Hires Sam Eldessouky As SVP And Corporate Controller  Benzinga
Valeant Pharmaceuticals Intl Inc. Cleans Shop. Is it a Buy Now?
On Wednesday, outgoing CEO Michael Pearson and one of the largest investors, Bill Ackman, testified before the Senate in connection to Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) raising the prices of drugs, in some cases 500-1,000%.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) To Admit to Wrong Doing  Market Exclusive
U.S. senate unmoved by Valeant Pharmaceuticals presenting itself as a ...  Financial Post
SEC Correspondence Adds To The Blow For Valeant Pharmaceuticals Intl Inc (VRX ...
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) received severe criticism from the Securities and Exchange Commission (SEC) for its use of its adjusted “non-GAAP” financial measures and its disclosure policies.
Stock Update (NYSE:VRX): Valeant Pharmaceuticals Intl Inc Provides Update ...
The Company announced that, on May 11, 2016, it applied for a customary management cease trade order (“MCTO”) from the Autorit� des march�s financiers (the “AMF”), the Company's principal securities regulator in Canada, relating to the trading in ...
Valeant Pharmaceuticals Intl Inc (VRX) Continues To Slide despite Rebate On ...  TCC
Most Active Options:, Inc. and Valeant Pharmaceuticals Intl Inc  Schaeffers Research (blog)
Valeant Pharmaceuticals Intl Inc (VRX) Options Traders Set a Short-Term Top
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is trading 5% lower at $25.03 -- and hit a five-year low of $23.55 earlier -- amid an onslaught of headlines.
Noticeable Analyst's ideas: Valeant Pharmaceuticals International, Inc. (NYSE ...
Valeant Pharmaceuticals International, Inc. (NYSE:VRX) accumulated +3.87%, closing at $27.12 after floating between $25.86 and $27.33.